Income Statement - Lyell Immunopharma, Inc. (LYEL)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 0.04 | 0.06 | 0.13 | 84.68 | 10.65 | 7.76 | 0.66 |
| Cost of revenue | 11.54 | 20.25 | 16.47 | 14.54 | 7.48 | ||
| Gross profit | -11.50 | 0.06 | 0.13 | 84.68 | 10.65 | 7.76 | 0.66 |
| Total operating expenses | 192.27 | 358.82 | 247.14 | 271.74 | 225.43 | 219.69 | 102.75 |
| Operating income | -203.77 | -358.76 | -247.01 | -187.06 | -214.78 | -211.94 | -102.09 |
| Non-operating income (net) | -70.67 | 15.76 | 12.38 | 3.94 | -35.44 | 7.47 | -27.29 |
| Income before tax | -274.45 | -342.99 | -234.63 | -183.12 | -250.22 | -204.47 | -129.38 |
| Income tax expense | -10.53 | -178.36 | 35.28 | -5.94 | -8.12 | ||
| Net income | -274.45 | -342.99 | -234.63 | -183.12 | -250.22 | -204.47 | -129.38 |
Show Quarterly Income Statement
Income Statement - Lyell Immunopharma, Inc. (LYEL)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0.00 | 0.01 | 0.03 | 0.03 | 0.07 | 48.39 | 0.00 | 35.74 | 0.55 | 2.82 | 2.76 | 2.63 | 2.45 | 2.31 | 1.07 | 3.12 | 1.26 |
| Cost of revenue | 2.33 | 2.40 | 3.14 | 5.03 | 4.90 | 5.02 | 5.06 | 5.10 | 4.54 | 5.03 | 4.59 | 4.17 | 3.73 | 3.97 | 3.99 | 3.00 | |||||||||
| Gross profit | -2.33 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0.00 | -5.04 | -5.08 | -4.51 | -4.96 | 43.79 | -4.17 | 32.01 | -3.42 | -1.17 | 2.76 | 2.63 | -0.55 | 2.31 | 1.07 | 3.12 | 1.26 |
| Total operating expenses | 43.83 | 61.32 | 37.27 | 47.15 | 57.37 | 201.16 | 50.54 | 51.54 | 55.58 | 54.79 | 55.50 | 61.36 | 59.49 | 59.79 | 62.52 | 69.04 | 67.28 | 47.17 | 51.92 | 65.34 | 45.40 | 41.84 | 37.91 | 105.68 | 34.26 |
| Operating income | -46.16 | -61.31 | -37.25 | -47.14 | -57.37 | -201.15 | -50.51 | -51.53 | -55.58 | -59.83 | -60.58 | -65.87 | -64.45 | -15.99 | -66.69 | -37.03 | -70.70 | -48.34 | -49.16 | -62.71 | -45.95 | -39.52 | -36.84 | -102.57 | -33.00 |
| Non-operating income (net) | 22.00 | -79.41 | -1.59 | 4.46 | 5.17 | 9.21 | 5.92 | 5.72 | -5.09 | 6.90 | 9.72 | 1.98 | -2.51 | 7.60 | -3.57 | 0.71 | 2.55 | -35.37 | 0.29 | 0.11 | -9.10 | 0.67 | 1.12 | 1.91 | 3.76 |
| Income before tax | -24.15 | -140.72 | -38.85 | -42.68 | -52.20 | -191.94 | -44.58 | -45.81 | -60.67 | -52.93 | -50.85 | -63.89 | -66.96 | -8.40 | -70.25 | -36.32 | -68.14 | -83.71 | -48.88 | -62.60 | -55.04 | -38.86 | -35.72 | -100.66 | -29.24 |
| Income tax expense | 4.98 | 5.01 | -6.61 | -2.34 | 65.67 | -2.45 | 3.82 | -0.95 | -0.43 | -0.32 | -0.27 | -0.22 | -0.35 | -1.29 | -1.10 | -1.88 | -2.34 | ||||||||
| Net income | -24.15 | -140.72 | -38.85 | -42.68 | -52.20 | -191.94 | -44.58 | -45.81 | -60.67 | -52.93 | -50.85 | -63.89 | -66.96 | -8.40 | -70.25 | -36.32 | -68.14 | -83.71 | -48.88 | -62.60 | -55.04 | -38.86 | -35.72 | -100.66 | -29.24 |